Clinical trials of WT1 peptide vaccine to gynecologic malignancies that are resistant to conventional therapies.

被引：0
|
作者：
Miyatake, T.
Enomoto, T.
Oka, Y.
Nishida, S.
Tsuboi, A.
Shirakata, T.
Morita, S.
Sakamoto, J.
Sugiyama, H.
Kimura, T.
机构：
[1] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan
[3] Osaka Univ, Grad Sch Med, Dept Canc Immunotherapy, Suita, Osaka, Japan
[4] Osaka Univ, Grad Sch Med, Dept Biomed Informat, Suita, Osaka, Japan
[5] Yokohama City Univ, Med Ctr, Dept Clin Stat, Yokohama, Kanagawa 232, Japan
[6] Nagoya Univ, Nagoya, Aichi 4648601, Japan
[7] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5081
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5081
引用
收藏
页数：1
相关论文
共 50 条
  • [1] WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial
    Miyatake, Takashi
    Ueda, Yutaka
    Morimoto, Akiko
    Enomoto, Takayuki
    Nishida, Sumiyuki
    Shirakata, Toshiaki
    Oka, Yoshihiro
    Tsuboi, Akihiro
    Oji, Yusuke
    Hosen, Naoki
    Nakatsuka, Shin-ichi
    Morita, Satoshi
    Sakamoto, Junichi
    Sugiyama, Haruo
    Kimura, Tadashi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (03) : 457 - 463
  • [2] WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial
    Takashi Miyatake
    Yutaka Ueda
    Akiko Morimoto
    Takayuki Enomoto
    Sumiyuki Nishida
    Toshiaki Shirakata
    Yoshihiro Oka
    Akihiro Tsuboi
    Yusuke Oji
    Naoki Hosen
    Shin-ichi Nakatsuka
    Satoshi Morita
    Junichi Sakamoto
    Haruo Sugiyama
    Tadashi Kimura
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 457 - 463
  • [3] WT1 peptide cancer vaccine for patients with hematopoietic malignancies and solid cancers
    Oka, Yoshihiro
    Tsuboi, Akihiro
    Elisseeva, Olga A.
    Nakajima, Hiroko
    Fujiki, Fumihiro
    Kawakami, Manabu
    Shirakata, Toshiaki
    Nishida, Sumiyuki
    Hosen, Naoki
    Oji, Yusuke
    Kawase, Ichiro
    Sugiyama, Haruo
    THESCIENTIFICWORLDJOURNAL, 2007, 7 : 649 - 665
  • [4] Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers
    Oka, Y.
    Tsuboi, A.
    Kawakami, M.
    Elisseeva, O. A.
    Nakajima, H.
    Udaka, K.
    Kawase, I.
    Oji, Y.
    Sugiyama, H.
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (20) : 2345 - 2352
  • [5] WT1 peptide vaccine for the treatment of cancer
    Oka, Yoshihiro
    Tsuboi, Akihiro
    Oji, Yusuke
    Kawase, Ichiro
    Sugiyama, Haruo
    CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (02) : 211 - 220
  • [6] The progress of peptide vaccine clinical trials in gynecologic oncology
    Tang, Mi
    Cai, Jiang-Hui
    Diao, Hao-Yang
    Guo, Wen-Mei
    Yang, Xiao
    Xing, ShaSha
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [7] WT1 Peptide Vaccine as a Paradigm for "Cancer Antigen-Derived Peptide"-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
    Oka, Yoshihiro
    Tsuboi, Akihiro
    Fujiki, Fumihiro
    Li, Zheyu
    Nakajima, Hiroko
    Hosen, Naoki
    Shirakata, Toshiaki
    Nishida, Sumiyuki
    Oji, Yusuke
    Kawase, Ichiro
    Sugiyama, Haruo
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (07) : 787 - 797
  • [8] Long term efficacy of WT1 peptide vaccination in patients with WT1 expressing AML /MDS and solid malignancies
    Lukas, K.
    Scheibenbogen, C.
    Asemissen, A. M.
    Busse, A.
    Ochsenreither, S.
    Blau, I
    Baldus, C.
    Thiel, E.
    Keilholz, U.
    Letsch, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 85 - 85
  • [9] Effective immune response induced by WT1 peptide vaccine
    Elisseeva, Olga
    Oka, Yoshihiro
    Tsuboi, Akihiro
    Harada, Yukie
    Fujiki, Fumihiro
    Oji, Yusuke
    Sugiyama, Haruo
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 661 - 661
  • [10] WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1
    Oji, Yusuke
    Kagawa, Naoki
    Arita, Hideyuki
    Naka, Norifumi
    Hamada, Ken-ichiro
    Outani, Hidetatsu
    Shintani, Yasushi
    Takeda, Yoshito
    Morii, Eiichi
    Shimazu, Kenzo
    Suzuki, Motoyuki
    Nishida, Sumiyuki
    Nakata, Jun
    Tsuboi, Akihiro
    Iwai, Miki
    Hayashi, Sae
    Imanishi, Rin
    Ikejima, Sayaka
    Kanegae, Mizuki
    Iwamoto, Masahiro
    Ikeda, Mayu
    Yagi, Kento
    Shimokado, Haruka
    Nakajima, Hiroko
    Hasegawa, Kana
    Morimoto, Soyoko
    Fujiki, Fumihiro
    Nagahara, Akira
    Tanemura, Atsushi
    Ueda, Yutaka
    Mizushima, Tsunekazu
    Ohmi, Masato
    Ishida, Takayuki
    Fujimoto, Manabu
    Nonomura, Norio
    Kimura, Tadashi
    Inohara, Hidenori
    Okada, Seiji
    Kishima, Haruhiko
    Hosen, Naoki
    Kumanogoh, Atsushi
    Oka, Yoshihiro
    Sugiyama, Haruo
    CANCERS, 2023, 15 (02)
12345